Investor Relations

Corporate Videos

The Future of Innovation In Pharmaceutical Oral Delivery Systems

Innovation As a Differentiation in Technology, Products and Culture

Company Overview

Procaps Group has experience in the development of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies that reach more than 50 countries in all five continents. We have direct presence in 13 countries in Latin America and we have more than 5,000 collaborators working under a sustainable model.

We develop, manufacture, and market over-the-counter (OTC) and prescription drugs, nutritional supplements and high-potential clinical solutions.

Investor Contact Information


Procaps Group
9 Rue de Bitbourg
L-1273 Luxembourg
Grand Duchy of Luxembourg

Investor Relations

Procaps Group Company Contact
Melissa Angelini
Investor Relations Director,